1h Free Analyst Time
The exosome diagnostics and therapeutics market is forecasted to grow by USD 1.01 billion during 2024-2029, accelerating at a CAGR of 26.5% during the forecast period. The report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by raising research on exosome therapeutics, increasing demand for effective drugs for chronic diseases, and growing focus on early detection of cancer.
The exosome diagnostics and therapeutics market is segmented as below:
By Application
- Diagnostic
- Therapeutic
By End-user
- Research and academic institutes
- Pharmaceutical and biotechnology companies
- Commercial
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the exosome diagnostics and therapeutics market covers the following areas:
- Exosome Diagnostics And Therapeutics Market sizing
- Exosome Diagnostics And Therapeutics Market forecast
- Exosome Diagnostics And Therapeutics Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global exosome diagnostics and therapeutics market: Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., HansaBioMed Life Sciences Ltd., Hologic Inc., JSR Life Sciences LLC, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN N.V., ReNeuron Group plc, Sarepta Therapeutics Inc., System Biosciences LLC, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advanced technology in exosome collection."
According to the report, one of the major drivers for this market is the raising research on exosome therapeutics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aethlon Medical Inc.
- Bio Techne Corp.
- BioCat GmbH
- BioVision Inc.
- Capricor Therapeutics Inc.
- Cell Guidance Systems Ltd.
- Clara Biotech Inc.
- Evox Therapeutics Ltd.
- HansaBioMed Life Sciences Ltd.
- Hologic Inc.
- JSR Life Sciences LLC
- Merck KGaA
- Miltenyi Biotec B.V. and Co. KG
- Nanosomix Inc.
- NX PharmaGen Inc.
- QIAGEN N.V.
- ReNeuron Group plc
- Sarepta Therapeutics Inc.
- System Biosciences LLC
- Thermo Fisher Scientific Inc.
